Background A number of reports have indicated an association between thyroid diseases and primary Sj？gren's syndrome (pSS). However, fewer studies have investigated whether the presence of thyroid diseases is associated with increased risk of developing pSS. Thus, the aim of our study was to use a nationwide health claims database to explore the prevalence and risk of pSS in female patients with thyroid diseases. Methods From the Registry of Catastrophic Illness database in the National Health Insurance Research Database in Taiwan, we identified 389 female patients with a diagnosis of pSS from 2005 to 2010. We also obtained 1945 control subjects frequency-matched on sex, 10-year age interval, and year of index date from the Longitudinal Health Insurance Database (LHID2000). Both groups were retrospectively traced back to a period of eight years to obtain diagnosis of thyroid diseases prior to index date. Results A significantly higher risk of pSS was associated with the presence of thyroid diseases (adjusted odds ratio (AOR) = 2.1, 95% confidence interval (CI) = 1.6–2.9). Among the sub-categories of thyroid diseases, patients with thyroiditis (AOR = 3.6, 95% CI = 1.7–7.5), thyrotoxicosis (AOR = 2.5, 95% CI = 1.6–3.8), and unspecified hypothyroidism (AOR = 2.4, 95% CI = 1.2–4.6), and simple and unspecified goiter (AOR = 2.0, 95% CI = 1.3–3.3) were significantly associated with increased risk of pSS. The associations were generally stronger in the mid-forties to mid-sixties age group, except in patients with unspecified hypothyroidism. Conclusions The risk of pSS was significantly increased in female patients with thyroid diseases, particularly those in their mid-forties to mid-sixties. An increased awareness of the possibility of pSS in perimenopausal females with thyroid diseases is important to preserve their quality of life and to avoid comorbidity.
References
[1]
Peri Y, Agmon-Levin N, Theodor E, Shoenfeld Y (2012) Sj？gren's syndrome, the old and the new. Best Pract Res Clin Rheumatol 26: 105–117.
[2]
Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, et al. (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58: 15–25.
[3]
Weng MY, Huang YT, Liu MF, Lu TH (2011) Incidence and mortality of treated primary Sjogren's syndrome in Taiwan: a population-based study. J Rheumatol 38: 706–708.
[4]
Kang JH, Lin HC (2010) Comorbidities in patients with primary Sjogren's syndrome: a registry-based case-control study. J Rheumatol 37: 1188–1194.
[5]
Jara LJ, Navarro C, Brito-Zerón Mdel P, García-Carrasco M, Escárcega RO, et al. (2007) Thyroid disease in Sj？gren's syndrome. Clin Rheumatol 26: 1601–1606.
[6]
Robazzi TC, Adan LF (2012) Autoimmune thyroid disease in patients with rheumatic diseases. Rev Bras Reumatol 52: 417–430.
[7]
Tektonidou MG, Anapliotou M, Vlachoyiannopoulos P, Moutsopoulos HM (2004) Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases. Ann Rheum Dis 63: 1159–1161.
[8]
Adamson TC 3rd, Fox RI, Frisman DM, Howell FV (1983) Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies. J Immunol 130: 203–208.
[9]
Kr？mer G, Sundick RS, Schauenstein K, Hála K, Wick G (1985) Analysis of lymphocytes infiltrating the thyroid gland of Obese strain chickens. J Immunol 135: 2452–2457.
[10]
Mavragani CP, Fragoulis GE, Moutsopoulos HM (2012) Endocrine alterations in primary Sjogren's syndrome: an overview. J Autoimmun 39: 354–358.
[11]
Coll J, Anglada J, Tomas S, Reth P, Goday A, et al. (1997) High prevalence of subclinical Sj？gren's syndrome features in patients with autoimmune thyroid disease. J Rheumatol 24: 1719–1724.
[12]
Bureau of National Health Insurance (2013) Regulations Governing the Exemption of the National Health Insurance Beneficiaries from the Co-Payment. Available: http://www.nhi.gov.tw/English/webdata/we？bdata.aspx?menu=11&menu_id=295&WD_ID=295？&webdata_id=2431. Accessed 4 July 2013.
[13]
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, et al. (2002) Classification criteria for Sj？gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61: 554–558.
[14]
Bjoro T, Holmen J, Krüger O, Midthjell K, Hunstad K, et al. (2000) Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur J Endocrinol 143: 639–647.
[15]
Liu CY, Hung YT, Chuang YL, Chen YJ, Weng WS, et al. (2006) Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey (in Chinese). J Health Manage 4: 1–22.
[16]
Warfvinge G, Larsson A, Henricsson V, Ericsson UB, Hansen B, et al. (1992) Salivary gland involvement in autoimmune thyroiditis, with special reference to the degree of association with Sj？gren's syndrome. Oral Surg Oral Med Oral Pathol 74: 288–293.
[17]
Gudbj？rnsson B, Karlsson-Parra A, Karlsson E, H？llgren R, K？mpe O (1994) Clinical and laboratory features of Sj？gren's syndrome in young women with previous postpartum thyroiditis. J Rheumatol 21: 215–219.
[18]
Franklyn JA, Boelaert K (2012) Thyrotoxicosis. Lancet 379: 1155–1166.
[19]
Vanderpump MP (2011) The epidemiology of thyroid disease. Br Med Bull 99: 39–51.
[20]
Biró E, Szekanecz Z, Czirják L, Dankó K, Kiss E, et al. (2006) Association of systemic and thyroid autoimmune diseases. Clin Rheumatol 25: 240–245.
[21]
Chen WS, Lin HD, Su KY, Lin DC, Wang HP, et al. (2007) A cohort study of autoimmune thyroid diseases in primary Sj？gren's syndrome in northern Taiwan. Formosan J Rheumatology 21: 20–25.
[22]
Punzi L, Ostuni PA, Betterle C, De Sandre P, Botsios C, et al. (1996) Thyroid gland disorders in primary Sj？gren's syndrome. Rev Rhum (Engl Ed) 63: 809–814.
[23]
Manji N, Carr-Smith JD, Boelaert K, Allahabadia A, Armitage M, et al. (2006) Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. J Clin Endocrinol Metab 91: 4873–4880.
